Simulate how genetic and drug interventions affect cell states and functions to identify the key genes, pathways, and regulatory mechanisms driving disease phenotypes, accelerating the discovery, prioritization, and validation of candidate targets.
Build virtual cells that respond to genetic, pharmacological, and environmental interventions, simulating state changes, functional responses, and fate transitions across cell types and biological contexts to support cell research and engineering design.
Integrate multicellular, multi-omics, spatial microenvironment, and longitudinal disease data to reconstruct disease states and their progression, understand cell–cell interactions and disease heterogeneity, and predict the systemic impact of different intervention strategies.
Drug Perturbation and Virtual Clinical Trials in the Tumor Microenvironment (TME)
AI-Optimized Directed Differentiation Process for Stem Cells
Genetic Engineering and Functional Optimization of CAR-T Cells
AI-Driven Discovery of Skin Anti-Aging Targets
Target Discovery
Simulate how genetic and drug interventions affect cell states and functions to identify the key genes, pathways, and regulatory mechanisms driving disease phenotypes, accelerating the discovery, prioritization, and validation of candidate targets.
Cell Simulation
Build virtual cells that respond to genetic, pharmacological, and environmental interventions, simulating state changes, functional responses, and fate transitions across cell types and biological contexts to support cell research and engineering design.
Disease Simulation
Integrate multicellular, multi-omics, spatial microenvironment, and longitudinal disease data to reconstruct disease states and their progression, understand cell–cell interactions and disease heterogeneity, and predict the systemic impact of different intervention strategies.
Platform Partnership
Rapidly validate the value of AIVC in real-world R&D, with model, platform, and R&D service support for our clients.
Data & Model Co-Development
Build high-quality biological data through joint projects and continuously improve model capabilities, creating long-term data and knowledge assets for both parties.
Joint Innovation
Co-develop new models, applications, and cell products around real research and industry needs to accelerate life science innovation.
制药企业
Pharma
Partnering with innovative biopharma and multinational pharmaceutical companies on tumor microenvironment (TME) modeling and drug response prediction. Through staged R&D milestones, we advance model validation and joint development to accelerate the use of virtual cell technology in oncology drug discovery.
生物技术公司
Biotech
Partnering with regenerative medicine and cell therapy companies, using virtual cell perturbation prediction to support stem cell directed differentiation, cell function regulation, and T cell engineering—opening new paths for cell therapy development.
Consumer Health Companies
Cosmetics & Longevity
Partnering with cosmetics and anti-aging companies on skin aging mechanisms, anti-aging target discovery, and active ingredient research, using cell state and perturbation response prediction to support the development of functional skincare and anti-aging products.
学术界
Academia
Partnering with hospitals and research institutions on disease mechanisms, gene function, and frontier life science questions, combining virtual cell predictions with experimental validation to support basic research and academic output.
研发服务机构
CRO
Partnering with patient-derived organoid (PDO), patient-derived xenograft (PDX), and clinical translational research service providers, integrating virtual cell predictions with experimental model data to support drug sensitivity studies, efficacy evaluation, and patient stratification.
Skin Anti-Aging Target Discovery
